From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

Dianne Bosch, Kim J. M. van der Velden, Aart Beeker, Hendrik P. van den Berg, André M. Bergman, Maarten J. van der Doelen, Alfons J. M. van den Eertwegh, Mathijs P. Hendriks, Thomas M. A. Kerkhofs, Addy C. M. van de Luijtgaarden, Niven Mehra, Reindert J. A. van Moorselaar, Metin Tascilar, Walter L. Vervenne, Nir I. Weijl, Carin A. Uyl-de Groot, Peter F. A. Mulders, Malou C. P. Kuppen, Inge M. van Oort

Open source

DOI: 10.1007/s40801-026-00548-8
Published: 2026-05-09
Container: Drugs - Real World Outcomes
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40801-026-00548-8,
  title = {From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer},
  author = {Dianne Bosch and Kim J. M. van der Velden and Aart Beeker and Hendrik P. van den Berg and André M. Bergman and Maarten J. van der Doelen and Alfons J. M. van den Eertwegh and Mathijs P. Hendriks and Thomas M. A. Kerkhofs and Addy C. M. van de Luijtgaarden and Niven Mehra and Reindert J. A. van Moorselaar and Metin Tascilar and Walter L. Vervenne and Nir I. Weijl and Carin A. Uyl-de Groot and Peter F. A. Mulders and Malou C. P. Kuppen and Inge M. van Oort},
  year = {2026},
  journal = {Drugs - Real World Outcomes},
  doi = {10.1007/s40801-026-00548-8},
  url = {https://doi.org/10.1007/s40801-026-00548-8}
}

RIS

TY  - JOUR
TI  - From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer
AU  - Dianne Bosch
AU  - Kim J. M. van der Velden
AU  - Aart Beeker
AU  - Hendrik P. van den Berg
AU  - André M. Bergman
AU  - Maarten J. van der Doelen
AU  - Alfons J. M. van den Eertwegh
AU  - Mathijs P. Hendriks
AU  - Thomas M. A. Kerkhofs
AU  - Addy C. M. van de Luijtgaarden
AU  - Niven Mehra
AU  - Reindert J. A. van Moorselaar
AU  - Metin Tascilar
AU  - Walter L. Vervenne
AU  - Nir I. Weijl
AU  - Carin A. Uyl-de Groot
AU  - Peter F. A. Mulders
AU  - Malou C. P. Kuppen
AU  - Inge M. van Oort
PY  - 2026
JO  - Drugs - Real World Outcomes
DO  - 10.1007/s40801-026-00548-8
UR  - https://doi.org/10.1007/s40801-026-00548-8
ER  -

APA

Bosch, D., Velden, K. J. M. V. D., Beeker, A., Berg, H. P. V. D., Bergman, A. M., Doelen, M. J. V. D., Eertwegh, A. J. M. V. D., Hendriks, M. P., Kerkhofs, T. M. A., Luijtgaarden, A. C. M. V. D., Mehra, N., Moorselaar, R. J. A. V., Tascilar, M., Vervenne, W. L., Weijl, N. I., Groot, C. A. U., Mulders, P. F. A., Kuppen, M. C. P., & Oort, I. M. V. (2026). From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer. Drugs - Real World Outcomes. https://doi.org/10.1007/s40801-026-00548-8

Source records

crossref · retrieved 2026-09-26T17:02:52.386Z